FDA approves immunotherapy drug combo for non-muscle invasive bladder cancer after UCLA-led research shows improved ...
BYLINE: Denise Heady Newswise — The U.S. Food and Drug Administration (FDA) has approved the immunotherapy-boosting drug N-803, which is marketed under the brand name Anktiva, to be used in combination with the immunotherapy Bacillus Calmette-Guerin (BCG) …